FBRX - Financial Reports List - Forte Biosciences, Inc. - IntrinsicAlpha

Forte Biosciences, Inc. FBRX

Healthcare - Biotechnology - NASDAQ - US

$ 7.01

-4.5 %

$ 46.1 M

Market Cap

-0.58

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-21.85%	-15.20%
Annual Report	FY	10-K	2024-12-31	0.00%	-12.71%	-12.67%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	15.70%	15.53%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-40.64%	-41.89%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-11.56%	-13.84%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-20.25%	-29.20%
Annual Report	FY	10-K	2023-12-31	0.00%	-127.07%	-133.78%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-194.79%	-198.45%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-191.67%	-199.14%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-153.85%	-172.67%

1